Your browser doesn't support javascript.
loading
Correction to: Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial.
Gyselinck, Iwein; Liesenborghs, Laurens; Landeloos, Ewout; Belmans, Ann; Verbeke, Geert; Verhamme, Peter; Vos, Robin; Janssens, W.
Afiliação
  • Gyselinck I; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium. iwein.gyselinck@kuleuven.be.
  • Liesenborghs L; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Landeloos E; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Belmans A; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
  • Verbeke G; Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Leuven, Belgium.
  • Verhamme P; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Vos R; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
  • Janssens W; Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven, Leuven, Belgium.
Trials ; 22(1): 187, 2021 Mar 05.
Article em En | MEDLINE | ID: mdl-33673831
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article